Can ayahuasca cure addiction?

Research shows promising but preliminary results. There is no evidence that ayahuasca 'cures' addiction. It is not FDA-approved and carries significant medical risks, including dangerous drug interactions.

Is ayahuasca legal in the US?

Ayahuasca contains DMT, a Schedule I substance. Its use is not broadly legal in the US, though some religious organizations have won legal exemptions. Most Americans access it through retreats in countries where it is legal or tolerated.

Ayahuasca carries real risks: dangerous interactions with common medications (SSRIs, stimulants), cardiovascular effects, psychological destabilization, and the unregulated nature of most retreat settings. Deaths have been documented.

Modern treatments

Ayahuasca retreats for addiction: What the science says and the risks

Published July 1, 2025 · 8 min read · Updated April 2026

Last medically reviewed: April 2026

Reviewed for accuracy by licensed clinical professionals. Editorial process.

Ayahuasca — a psychoactive brew traditional to Amazonian indigenous cultures — has attracted significant interest as a potential treatment for addiction, depression, and PTSD. Retreat centers marketing ayahuasca for addiction recovery have proliferated, particularly in Central and South America. But separating the science from the marketing requires careful examination.

What the research shows

Observational studies and small clinical trials have shown promising results. Participants in ayahuasca ceremonies report reduced substance cravings, increased motivation for change, enhanced self-awareness and emotional processing, and spiritual experiences that provide meaning and purpose. However, most studies are observational (not randomized controlled trials), have small sample sizes, lack long-term follow-up, and cannot separate the effects of the substance from the effects of the ceremonial setting, community, and expectation. The research is intriguing but far from conclusive.

The risks

Ayahuasca carries real medical risks. It contains MAO inhibitors that interact dangerously with many common medications — SSRIs, SNRIs, stimulants, and certain opioids. These interactions can cause serotonin syndrome, a potentially fatal condition. Cardiovascular effects (elevated heart rate and blood pressure) pose risks for people with heart conditions. Intense psychological experiences can trigger or worsen psychotic symptoms in vulnerable individuals. The unregulated nature of most retreat centers means no standardized dosing, inconsistent quality of the brew, limited medical screening, and inadequate emergency response capabilities. Deaths at ayahuasca retreats have been documented.

The ethical concern

Marketing ayahuasca as a "cure" for addiction to desperate, vulnerable people — many of whom have failed other treatments — is ethically problematic, particularly when the evidence base is preliminary and the risks are real. If you are considering ayahuasca, do so with clear-eyed awareness: it is not FDA-approved, the evidence is early-stage, the risks are significant, and it is not a substitute for evidence-based treatment.